Abstract 5652: Preclinical development of LUA011, a novel CDH17/cMET bispecific ADC with enhanced antitumor efficacy and mitigated gastrointestinal toxicity.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Qilu Pharmaceutical Co., Ltd. (China)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148888096
Cites:
Cited by:
Related to: